Treating osteoporosis in adults over 80 significantly reduces the risk of future fractures and supports healthier aging after ...

People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, ...

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...

Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease ...

People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a ...

Our findings demonstrate that the mutational landscape of BPDCN is similar to that observed in other myeloid neoplasms, and we identified CCDC50 as a ...

Researchers determined the presence of pulmonary hypertension was associated with worse outcomes for patients with polycythemia vera.